Category Archives: Ethics

Individual Mandate: Be careful what you wish for

Be careful what you wish for.  This cuts both ways.

The incidental economist notes: (Austin Frakt)

If one wants to address the problems in health insurance markets and/or to get providers to accept payment reforms, the mandate–or something like it–is the political price. Yes, it’s about money. What else?

Put it this way, if one wants to retain a private market-based health insurance system (which ours largely is), it takes a mandate. Reject the mandate without replacement with a similar mechanism and the whole thing unravels, not just as a matter of health economics (adverse selection) but as a matter of politics.

Medicynical Note:  We’ve created the most dysfuntional, expensive healthcare non-system in the world.  Yes we’re number one.

Employer sponsored health care is a mess.  Employers don’t have to provide their employees health care–in many instances they can’t afford to provide it; “contractors” are not employees and don’t qualify for employer provided benefits;  if you get sick and can’t work, you lose your insurance.  Remarkable.

Our health care costs are twice that of many other industrialized countries and thousands more per capita/year.  We have 50 million uninsured and have a “system” that encourages “free” use of the most inefficient, most expensive health care provider in the country–emergency rooms.

We all pay.

25% Overuse of Implantable Cardioverter (ICD)

As noted in JAMA, implantable cardioverters are being overused. 25% of patients in the study cited did not have the accepted indications for this expensive procedure. Furthermore:

Patients who received a non–evidence-based ICD compared with those who received an evidence-based ICD had a significantly higher risk of in-hospital death (0.57% [95% confidence interval {CI}, 0.48%-0.66%] vs 0.18% [95% CI, 0.15%-0.20%]; P <.001) and any postprocedure complication (3.23% [95% CI, 3.01%-3.45%] vs 2.41% [95% CI, 2.31%-2.51%]; P <.001).

Medicynical Note: We think of the art of medicine as making treatment decisions using science as well as instincts based on the provider’s unique knowledge of the patient, local standards and what is medically indicated.

In the JAMA study 25% of patients received ICD’s did not have the established indications for the procedure and as a group these patients had worse outcomes. Presumably their doctors felt the use of the ICD indicated (applying the “art of medicine”). As costs have increased (an ICD procedure is $50,000 or more) and better tracking of outcomes reveal that overuse leads to more complications and worse outcomes, I’m not sure we can afford this type artistry.


The Game of Health Care — Another Great Moment in Medicine

I can recall a MAD Magazine illustration series (drawn by Kelly Freas) called “Great Moments in Medicine.” It was a parody of one of the “ethical” pharmaceutical company’s ad campaigns. Except in the MAD magazine case the great moment was presenting the bill.


In today’s Times there is another great moment.   Drug companies distributing coupons to decrease co-pays on their expensive drugs so as  to increase their  use rather than equally effective less expensive generics. With the coupon the patient’s out of pocket expense was the same. but for  insurers the cost was many times more. Guess who pays for this with increased insurance premiums?

Drug companies say the plans help some patients afford medicines that they otherwise could not.

But health insurers and some consumer groups say that in many cases, the coupons are just marketing gimmicks that are leading to an overall increase in health care costs. That is because they circumvent the system of higher co-pays on costlier drugs that insurers use to encourage consumers to use less expensive products.

One example was a one a day patented formulation of the generic drug minocycline:

A month’s supply of Solodyn sells for more than $700 on drugstore.com, compared with about $40 a month for capsules of generic minocycline, which are generally taken twice a day.

Almost 20 times the cost.

Medicynical Note: Is it any wonder that our non-system of health care is bankrupting us?

Suppliers (and insurers at times) game the system to maximize profits. Patient care? Cost efficiency? Not our department.

 

Spinal Fusion Surgery — Big benefit to doctors, limited benefit to patients

Bloomberg has an interesting article on the limited medical benefit of spinal fusion to patients–but big financial benefits to doctors, medical practices and suppliers (Medtronic). The article documents at least the appearance of, if not actual, conflicts of interest; high costs $135,000 for the surgery (yes on one patient); $800,000/year incomes for the orthopedists–three times that of pediatricians.

The possibility that many of these and other surgeries are needless has gotten little attention in the debate over U.S. health care costs, which rose 6 percent last year to $2.47 trillion. Unnecessary surgeries cost at least $150 billion a year, according to John Birkmeyer, director of the Center for Healthcare Outcomes & Policy at the University of Michigan.

“It’s amazing how much evidence there is that fusions don’t work, yet surgeons do them anyway,” said Sohail Mirza, a spine surgeon who chairs the Department of Orthopaedics at Dartmouth Medical School in Hanover, New Hampshire. “The only one who isn’t benefitting from the equation is the patient.”

There’s lots to this article including evidence that fusion is no better than physical therapy for disc related pain in several studies–only a 47% success rate for surgery in one U.S. study;  high complication rates for surgery;  direct payments from the medical supplier (Medtronic) in the form of royalties and consulting fees to doctors (as high as $440,000/year to an individual doctor and 1.75 million to a practice in Minneapolis).

Medicynical note: Not a pretty picture of American medicine. Costly, open conflicts of interest, use of aggressive expensive unproven procedures over more conservative approaches–with the same or worse outcomes.  Is it any wonder that our costs are one and half to two times that of other industrialized countries.

The “free market” encourages entrepreneurs to find ways to take advantage of markets, sometimes that leads to better outcomes and more efficiency but in medicine it seems to encourage waste, high cost and over-utilization.

Hospital Saves Mother, Loses Catholic Hospital Status

When churches do religion they apparently do it well. When they choose to practice medicine they bungle, despite their “infallibility.”

In this situation the hospital, after doing an appropriate ethical review, saved the life of a woman having life threatening complications from a pregnancy– hypertension, probably eclampsia.

The church’s reaction to this life saving act:

The Roman Catholic Diocese of Phoenix stripped a major hospital of its affiliation with the church Tuesday because of a surgery that ended a woman’s pregnancy to save her life.  

The woman is in her 20s had a history of abnormally high blood pressure when she learned of her pregnancy. After she was admitted to the hospital with worsening symptoms, doctors determined her risk of death was nearly 100 percent.

Medicynical note: If a loved one were pregnant, I would not advise using a hospital blindly adhering to the catholic church’s wishes. Medieval notions in the modern era unfortunately lead to remarkable distortions which in this case threatened life.

Urologist Owned Radiation Facility (IMRT) = Expensive Conflict of Interest

WSJ notes the overuse of IMRT (intensity modulated ratiation therapy) at great cost to patients, medicare, other insurers and our health care non-system.

In recent years a number of urology groups have puchased and own radiation centers. The result is costly self referrals and obvious conflicts of interest. Here’s how it works.

urologists buy radiation equipment and hire radiation oncologists to administer it. They then refer their patients to their in-house staff for treatment. The bulk of Medicare’s reimbursements goes to the urologists as owners of the equipment.

The problem is not patient outcomes or fewer complications but rather overuse of an effective form of treatment to the financial benefit of the providers.

Asked during the interview what proportion of its prostate-cancer patients Integrated Medical treats with IMRT, Dr. Kapoor said he didn’t track such data closely, but said he would be “comfortable” with an estimate of “one out of six,” or 17%.

An analysis of Integrated Medical’s Medicare claims later performed for the Journal suggested a much higher rate. Between its launch in mid-2006 and the end of 2008, Integrated Medical administered IMRT to 601, or 53%, of 1,132 Medicare patients recently diagnosed with prostate cancer, the Journal analysis found.

Integrated Medical received $26.7 million from Medicare for the care of those 601 patients, according to the Journal’s calculations. If Integrated Medical’s urologists hadn’t owned radiation equipment and had referred these patients for radiation treatment outside of their practice, Medicare would have paid them only $2.6 million. Medicynical note: The data on treatment of patients over 80 discussed in the WSJ article is particularly damning.

The sales pitch to urologists considering buying such a radiation facility predicts an income of $425,000/doctor from incorporating such a unit in his/her practice.

Medicynical Note: This behavior falls into a loop hole of the Stark provisions against self referral. Read the article for a more complete explanation. The doctor’s position that their treatment decisions are based solely on patient benefit would be more defensible if they did not participate in the entire revenue stream and if the radiation modality did not appear to be overused.

What’s depressing is that there seems no incentive to provide care at a more reasonable price (value).   Rather than take a cut in the  generous $425,000/year doctor profit  (this in addition to his/her other fees) these providers stick it  to our failing health care non-system.

With everyone at every level  concerned with  maximizing profit, is it any wonder that we spend 17% of GDP on health?  That our health care insurance system is failing? and that we can no longer afford it!

This is going on during a disastrous financial downturn.  But then again considering the behavior of our financial sector, maybe it’s a natural consequence of a medical establishment whose primary goal seems to be monetary rather than medical.


Our Health Care System: Inefficiency, is that a problem?

The Washington Times presents a tortured argument against promoting more efficient care in the most expensive health care non-system in the world.

Think of it, a centralized, federal database tracking your every visit to a health care provider – where you went, who you saw, what was diagnosed and what care was provided. Chilling.  Medicynical note: as if private insurers oversight that  controls and limits treatment given is less intrusive, or as if the data will have patient identifiers.

The Times takes issue with the notion of efficiency in health care.  To them, apparently,   spending 50% more per capita on health care than any other nation in the world and 17% of GDP, and increasing yearly, is acceptable:

There is no telling what metrics will be used to define the efficiencies, but it is clear who will bear the brunt of these decisions. Those suffering the infirmities of age, surely, and also the physically and mentally disabled, whose health costs are great and whose ability to work productively in the future are low. And how will premature babies fare under the utilitarian gaze of Washington’s health efficiency experts? Will our severely wounded warriors be forced to forgo treatments and therapies based on their inability to be as productive as they once might have been? And will the love between a parent and child have a column on the health bureaucrats’ spreadsheets?

The Times then goes on to compare cost efficacy measures with the nazis.

Medicynical note: Nothing surprising here. Until we show some will to control  costs our non-system caring for an aging increasingly health care needy population will continue to spend our nation’s wealth.

Our republican friends have been amazingly quiet about their solutions. Their “free market” rhetoric leads one to assume they would put an increasingly large burden of expense on individuals–their form of individual mandate. They would then let the costs of health care assure economic rationing. For those who can’t afford care, I suppose their solution for patients is that of 18th century France and will let them eat cake.

Starbucks — More spent on health care than coffee

It’s remarkable how shortsighted American businesses are. Their Chamber of Commerce is on record as opposing health reform.  Given the cost of providing employees health insurance one would think they would be supportive of  reform efforts, particularly if they removed health insurance as an employee benefit, as is the case in most industrialized countries.

Consider the bankruptcies of GM and Chrysler due in part to health insurance costs; consider also Starbucks which provides health care for employees, “a line item that tallies $300 million. That’s more than the company spends on coffee.”

Medicynical note: In other countries businesses don’t have to factor the health coverage burden into their planning, or costs. It’s another of those incomprehensible inefficiencies that is uniquely American.

More Conflicts of Interest–Zimmer Holdings and Dr. Berger

After receiving 8 million dollars from Zimmer Holdings an orthopedic implant maker guess whose devices Dr. Berger recommended–until they began to fall apart in patient’s bodies.

For years, Dr. Richard A. Berger designed surgical tools and artificial joints for Zimmer Holdings, trained hundreds of doctors to use its products and talked it up wherever he went. In return, Zimmer, an orthopedic implant maker, helped enrich Dr. Berger, portraying him as a master surgeon and paying him more than $8 million over a decade.

Amid the booming use of artificial joints in the United States, the breakup between Dr. Berger and Zimmer highlights what experts say is a troubling situation for patients and doctors: when disputes arise about orthopedic implant safety, there are no independent referees or sources of information because no one tracks the performance of the devices.

Medicynical Note: This is not just the appearance of a conflict of interest. Patients are a nuisance to these guys, simply a means to huge earnings. Quality of care? Value? Ethics? Guess who pays?


Doctors on the Take: Conflicts of interest in Hip Replacement Surgery

Conflicts of interest affect outcomes as noted in this article on “new hips.”

Wright paid tens of thousands of dollars to a foundation Keggi helps run and gave him a trip to a conference in the Bahamas. Keggi recommended the ceramic device over the kinds of implants used in 97 percent of cases.

The ceramic joint made by Wright Medical Group Inc. shattered, leading to an infection and four more surgeries that left Hirschbeck permanently sidelined.

And costs:

The companies increased doctor compensation for 2008 to about $300 million, according to the data compiled by Bloomberg from reports posted on the device makers’ websites. Fees for 2008 were delivered in 2009, the surgeons say.

More on costs:

The financial ties between device makers and surgeons help explain why health-care costs in the U.S. rose at 2.5 times the rate of inflation in the past 10 years and account for a sixth of the economy. The $300 million works out to $300 for each of the 1 million hips and knees implanted in Americans in 2008.

In the U.S. in 2010, the average price of a primary artificial hip was $7,200, more than four times the $1,600 in Germany, says Melissa Hussey, a senior analyst on the orthopedic team at Millennium Research Group, based in Toronto. In Germany and other countries, she says, sales representatives have restricted access to surgeons.

Medicynical Note: So much for the “free market” system. Without regulation and limits companies will work endlessly to manipulate markets to their financial benefit. Are we fools or what?